Skip to content
Subscriber Only

Sanofi Recalls Tuberculosis Vaccine Amid Sterility Worry

Sanofi voluntarily recalled four batches of Bacillus Calmette-Guerin tuberculosis vaccine because the product’s sterility can’t be assured, Australia’s drugs regulator said.

The supply interruption may cause a shortage of the vaccine in Australia while alternatives are sought, the Therapeutic Goods Administration in Canberra said in a June 20 statement on its website. The recall was classified “class II,” meaning the defects may cause illness or mistreatment.